source
- TCGX launches $600 million Asia-focused biotech fund to back life-science companies in China and the regionTCGX, a biotech investment firm led by Chen Yu and Dandan Dong, announced a new $600 million fund aimed at the Asian market. The fund will make direct investments in life-science companies located…
- CAR-T biotech Caribou Biosciences halts two programs and seeks exit after funding shortfallCaribou Biosciences announced it is suspending two of its allogeneic CAR-T cell therapy projects. The company said it could not obtain the financing needed to keep the programs alive and is now lo…